P185
Photodynamic Inactivation of Candida albicans with Imidazoacridinones: Influence of Irradiance, Photosensitizer Uptake and Reactive Oxygen Species GenerationFactors Determining Staphylococcus aureus Susceptibility to Photoantimicrobial Chemotherapy: RsbU Activity, Staphyloxanthin Level, and Membrane Fluidity.The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection.High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus.European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypesMultiresistant strains are as susceptible to photodynamic inactivation as their naïve counterparts: protoporphyrin IX-mediated photoinactivation reveals differences between methicillin-resistant and methicillin-sensitive Staphylococcus aureus strainAn initial assessment of correlations between host- and virus-related factors affecting analogues antiviral therapy in HBV chronically infected patientsDynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS.Antimicrobial photodynamic therapy with fulleropyrrolidine: photoinactivation mechanism of Staphylococcus aureus, in vitro and in vivo studiesFine-tuning recA expression in Staphylococcus aureus for antimicrobial photoinactivation: importance of photo-induced DNA damage in the photoinactivation mechanism.Photoinactivation of Staphylococcus aureus using protoporphyrin IX: the role of haem-regulated transporter HrtA.The agr function and polymorphism: impact on Staphylococcus aureus susceptibility to photoinactivation.Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy.The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances.Inhibition of cancer antioxidant defense by natural compounds.Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus strains for clinical medicine.Current molecular methods for the detection of hepatitis B virus quasispecies.Discovering the mechanisms of strain-dependent response of Staphylococcus aureus to photoinactivation: oxidative stress toleration, endogenous porphyrin level and strain's virulence.Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit.Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA.Evaluation of the role of the pharmacological inhibition of Staphylococcus aureus multidrug resistance pumps and the variable levels of the uptake of the sensitizer in the strain-dependent response of Staphylococcus aureus to PPArg(2)-based photodynIs there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.Genetic variability of hepatitis B virus isolates in Poland.Hepatitis delta virus infection in chronically HBV-infected patients from northern Poland.Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain-dependent.Association between uridin diphosphate glucuronosylotransferase 1A1 (UGT1A1) gene polymorphism and neonatal hyperbilirubinemia.Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.mRNA heptaplex protocol for distinguishing between menstrual and peripheral blood.mRNA profiling for vaginal fluid and menstrual blood identification.(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry.Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challengeAssociations of ESR1 and ESR2 gene polymorphisms with metabolic syndrome and its components in postmenopausal womenDetection of Helicobacter rodentium-like DNA in the liver tissue of patients with chronic liver diseases by polymerase chain reaction–denaturing gradient gel electrophoresis and DNA sequence analysisAntimicrobial blue light photoinactivation of Pseudomonas aeruginosa: Quorum sensing signaling molecules, biofilm formation and pathogenicity
P50
Q28547979-1AB751A9-EEBC-4D26-9F74-7370042F9D5AQ30391403-F1615C66-58DC-4F6A-8F20-03643C4DCDA5Q33526884-BDFEDBB4-6F16-4771-8237-1EA63A795EB2Q33600034-EFF82EFD-0DD5-4DBC-A9E1-A6E105B67D10Q34864591-81424AF0-CFEC-40EC-82C0-E353B8D9CC16Q34997985-4AF474DB-54D3-4552-A3D5-E151FFF32547Q35073136-0F72A325-CB1A-4805-9A55-D6488F7F618DQ35094264-01E57727-E07A-46A1-8D9A-E112EB6AE78AQ35102963-9DB07483-ECA6-44E2-B7C9-5751E0BE34ACQ35556793-C68D597A-6154-4039-B6FB-E84E3E4A32EFQ35597701-DA5F5774-97A1-41A5-AB7B-7DDB5158B056Q36203467-84B883CE-3DA6-4173-9F38-FF3D5DC0603FQ36474873-0FB3CEBE-B8EB-41FF-8646-2A248E4D9EB2Q36668315-CF553009-10CD-4E14-BAF8-A389BD2486CEQ37159400-8097D2D3-D96C-4DF0-8EFC-BA690BE27C55Q37249982-8B72F20F-8882-4E52-8CB4-B13525DBD36AQ37716657-64FF72D6-5C51-4243-AF68-D287816C0B92Q37764726-16E3E64D-19E1-42AC-8C6E-A83F718790F2Q38923073-DF7883B6-BECD-42CD-BE50-A34D161E7818Q39053309-88502A7E-22EF-413B-ABCB-5130847465FFQ39413233-C897669A-8F03-478E-911B-71AFC82CD5C0Q39872871-FB776E73-09D5-4DB3-BF25-663CB0313671Q40152038-3EC1D95B-A401-424B-9B4F-323A5B74235DQ42970631-BB1E036E-B282-4F04-B87F-20F5E65ACD8CQ43033166-FAE02EC0-93D9-443D-B86A-17A3BED9AC4BQ43949193-93D53653-EC5F-4F53-9430-6966EFAACDA6Q45415311-078A8C29-8BEC-4363-865B-A5212A51CE22Q45421233-50766842-F396-46DE-ABC9-5537F4D9278CQ46840925-1304229B-846F-4960-9B18-B92772793351Q47397112-1126F72C-68A7-4A13-A491-BE817FE4003AQ47737887-20172B99-711F-4F4A-A702-69A2C08CA6B5Q47835684-8646F3C8-BD50-4296-8CFF-524369A84967Q54196307-20684B3E-0875-4040-8192-E1443D15A0E5Q54277835-D4FFD395-FD79-41F4-997D-D7A0E0ECCF24Q54597501-C4EE343D-A70F-4C75-9E4F-BF6FEE161DE0Q54643024-4EDC5711-3B89-43BD-ACC5-F78E0763C294Q56947386-F7FD567E-19A9-417A-A671-7188CBFB6279Q57165279-EB864F4D-5651-40D0-BDE1-7446D868E44EQ58837380-C8C62750-AF5C-4EB0-8C74-4E57BF6947E4Q59357998-52D0F7AE-B9EE-4B36-A8F3-DB0C6DE3FDC5
P50
description
Pools onderzoeker
@nl
hulumtues
@sq
polski biolog molekularny
@pl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Krzysztof Bielawski
@ca
Krzysztof Bielawski
@cs
Krzysztof Bielawski
@gl
Krzysztof Bielawski
@hr
Krzysztof Bielawski
@hsb
Krzysztof Bielawski
@it
Krzysztof Bielawski
@ro
Krzysztof Bielawski
@sk
Krzysztof Piotr Bielawski
@ast
Krzysztof Piotr Bielawski
@en
type
label
Krzysztof Bielawski
@ca
Krzysztof Bielawski
@cs
Krzysztof Bielawski
@gl
Krzysztof Bielawski
@hr
Krzysztof Bielawski
@hsb
Krzysztof Bielawski
@it
Krzysztof Bielawski
@ro
Krzysztof Bielawski
@sk
Krzysztof Piotr Bielawski
@ast
Krzysztof Piotr Bielawski
@en
altLabel
Krzysztof Bielawski
@ast
Krzysztof Bielawski
@en
Krzysztof Bielawski
@pl
Krzysztof Bielawski
@sl
Krzysztof Piotr Bielawski
@en
Krzysztof Piotr Bielawski
@pl
prefLabel
Krzysztof Bielawski
@ca
Krzysztof Bielawski
@cs
Krzysztof Bielawski
@gl
Krzysztof Bielawski
@hr
Krzysztof Bielawski
@hsb
Krzysztof Bielawski
@it
Krzysztof Bielawski
@ro
Krzysztof Bielawski
@sk
Krzysztof Piotr Bielawski
@ast
Krzysztof Piotr Bielawski
@en
P106
P108
P214
P108
P1153
7003278886
P1412
P1559
Krzysztof Bielawski
@pl
P184
P21
P213
0000 0001 1425 4333
P214
P27
P31
P3124
P496
0000-0002-5812-6314
P569
1950-01-01T00:00:00Z
P7293
9810540870005606
P734
P7859
viaf-167198124